| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/28/2008 | US20080051361 Intraocular pressure-related conditions, namely glaucoma; administering to the eye of the patient an interfering RNA molecule that attenuates expression of the GREM1 mRNA via RNA interference |
| 02/28/2008 | US20080051345 Pharmaceutical compositions comprising fragments and homologs of troponin subunits |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080050442 Nasal pharmaceutical formulations and methods of using the same |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050335 Ophthalmic Solutions |
| 02/28/2008 | US20080050317 Oleaginous pharmaceutical and cosmetic foam |
| 02/28/2008 | CA2661827A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 02/28/2008 | CA2659464A1 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 02/28/2008 | CA2658835A1 Use of pkc inhibitors in ocular diseases |
| 02/27/2008 | EP1892289A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891969A2 Novel anti-allergic agents |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1318994B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 02/27/2008 | EP1163000B1 Vaccine against antigens from bacteriae |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | EP1141278B1 Therapeutic pde4d phosphodiesterase inhibitors |
| 02/27/2008 | CN101132790A 维生素混合物 Vitamin mixture |
| 02/27/2008 | CN101132784A Ophthalmic uses of S1P receptor modulators |
| 02/27/2008 | CN101130083A Ophthalmic composition, producing method and use of the same |
| 02/27/2008 | CN101130071A Vaccine |
| 02/27/2008 | CN101130058A Emulsion of cyclosporin A for eyes and method of producing the same |
| 02/27/2008 | CN101129889A Oral liquid of coix seed |
| 02/27/2008 | CN101129837A Proprietary Chinese medicine for treating retina affection of diabetes |
| 02/27/2008 | CN101129836A Chinese medicine preparation for treating retina affection of diabetes |
| 02/27/2008 | CN101129835A Traditional Chinese medicine composition for treating retina affection of diabetes |
| 02/27/2008 | CN101129801A Proprietary Chinese medicine for treating retina affection of diabetes |
| 02/27/2008 | CN101129800A Chinese medicine preparation for treating retina affection of diabetes |
| 02/27/2008 | CN101129698A Eye drops containing turmeric extractive and preparation method thereof |
| 02/27/2008 | CN101129645A Anti-inflammation detoxication drink |
| 02/27/2008 | CN101129619A Liangjingjing eye plaster |
| 02/27/2008 | CN101129610A Vitality raising pill of glutinous rehmannia |
| 02/27/2008 | CN101129609A Chrysanthemum powder forimproving acuity of vision |
| 02/27/2008 | CN101129600A Gentian powder for improving acuity of vision |
| 02/27/2008 | CN101129588A Medicinal granules for conjunctivitis |
| 02/27/2008 | CN101129506A Capsule pill drops for treating electro-optical eye and anti-inflammation detoxication |
| 02/27/2008 | CN101129408A Ice musk deer medicine for dispelling imflammation |
| 02/27/2008 | CN101129399A Naphazoline hydrochloride chterphenarmine maleate and vitamin eye drops and preparation method thereof |
| 02/27/2008 | CN101129392A Aspartic vitamin eye drops and preparation method thereof |
| 02/27/2008 | CN101129386A Partial suspended eye drop containing ciprofloxacin and dexamethasone |
| 02/27/2008 | CN101129385A Ophthalmic composition containing gatifloxacin and lotepredenol etabonate and method of preparing the same |
| 02/27/2008 | CN101129359A Pharmaceutical composition containing amoxicillin, ambroxol and beta lactamase restrainer and uses thereof |
| 02/27/2008 | CN101129350A Eye drops used for treating cataract and cloudy vitreous turbidity of persons in middle and old age, and method for preparing the same |
| 02/27/2008 | CN100371018C Calcitonin composition |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370979C Preparation process of glucose eye lotion |
| 02/27/2008 | CN100370971C Phacolysin eye medicinal formulation |
| 02/26/2008 | US7335803 Methods and compositions for modulating alpha adrenergic receptor activity |
| 02/26/2008 | US7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335676 Methods for treating inflammatory conditions or inhibiting JNK |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | CA2430592C New pharmaceutical compositions based on anticholinergics and dopamine agonists |
| 02/21/2008 | WO2008021933A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 02/21/2008 | WO2008021729A2 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 02/21/2008 | WO2008021728A2 Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020081A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 02/21/2008 | WO2008020032A1 Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | US20080045605 Image Quality in the Eye |
| 02/21/2008 | US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2008 | US20080045566 6-substituted isoquinoline derivatives |
| 02/21/2008 | US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal |
| 02/21/2008 | US20080045529 Use Of Thienopyrimidines |
| 02/21/2008 | US20080045509 Substituted benzyl amine compounds |
| 02/21/2008 | US20080045508 Substituted aminomethyl benzamide compounds |
| 02/21/2008 | US20080045507 Substituted benzamide modulators of the histamine h3 receptor |
| 02/21/2008 | US20080044495 Extract of plant Dendrobii Caulis and preparing process thereof |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660608A1 Therapeutic lactams |
| 02/21/2008 | CA2660489A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 02/21/2008 | CA2660308A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/20/2008 | EP1889620A1 Eye drop containing roflumilast |
| 02/20/2008 | EP1888618A2 Analogs of glycyl-prolyl-glutamate |
| 02/20/2008 | EP1589992A4 Method for treating elevated intraocular pressure, including glaucoma |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | CN101128212A Drugs for nerve cell regeneration |
| 02/20/2008 | CN101128193A Anti-radical agents |
| 02/20/2008 | CN101125165A Traditional Chinese medicine for treating deaf |
| 02/20/2008 | CN101125146A Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369604C Drop pill type eye drip fluid of chloramphenicol, and preparation method |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |